Background: Bone marrow transplantation using donors with minor ABO incompatibility may
result in the rapid production of donor‐derived red cell isohemagglutinins, causing …

A 26‐year‐old, blood group O bone marrow transplant recipient experienced a severe,
delayed hemolytic transfusion reaction 6 days following transplantation of marrow from his …

BACKGROUND: Major ABO incompatibility of a bone marrow donor and recipient entails the
risk of severe hemolytic transfusion reactions. STUDY DESIGN AND METHODS: Nineteen …

BACKGROUND: Bone marrow transplantation with minor ABO incompatibility may be
followed by moderate delayed hemolysis of the recipient's red cells by donor‐derived ABO …

Hemolysis most commonly occurs following bone marrow transplant when there is “minor”
ABO blood group incompatibility between donor and recipient. The hemolysis has been …

ABO incompatibility is not a barrier to allogeneic stem cell transplant but may result in acute
hemolytic reactions. As stem cell product manipulation is cumbersome, we are reporting the …

Immune haemolysis as a result of minor ABO incompatibility is an underappreciated
complication of haematopoietic transplantation. The increased lymphoid content of …

The management of hemotherapy in 31 cases of ABO‐or Rh‐incompatible bone marrow
transplantation is described. Our experience confirms that ABO or Rh incompatibility does …

We investigated the changes in isoagglutinin titres in 62 patients who underwent ABO‐
incompatible allogeneic stem cell transplantation. After major [and/or (±) minor] ABO …

ABO incompatibility affects approximately 40% of allogeneic stem cell transplants in
Caucasian patient populations. Because bone marrow (BM), the preferred graft from …